filtration - Bioprocess Development Forum

Articles Downstream Downstream Multimedia

August 22, 2024

Download the infographic about viral vector manufacturing

Crafting a downstream viral vector process that's budget-friendly and GMP-ready is no small feat. But…

Ross Burns

Articles Downstream

August 22, 2024

Regulatory considerations for virus filtration process development

Virus filtration is a robust mechanism to ensure virus safety of biotherapeutic manufacturing processes and…

Ross Burns

Articles Downstream

July 25, 2024

Considerations in depth filter scale-up

Depth filters are widely used in the biopharmaceutical industry. They are typically made of a…

Ross Burns

Articles Downstream

February 22, 2024

Detailed agenda for Chromatography + filtration virtual summit

Join Cytiva Chromatography and filtration summit online to learn from presentations, live Q&A, and panel…

admin-element

Articles Downstream

February 9, 2024

Register to the Chromatography + Filtration Virtual Summit 2024

Explore the latest advancements in process development and scale-up 5-7 March, 2024 - 15:00...

admin-element

Events

November 29, 2023

Virus safety challenges: get the job done!

Virus safety is key in bioprocessing. In this free 1-day seminar you’ll learn how to…

admin-element

Articles

September 21, 2023

High-concentration monoclonal antibody drugs: manufacturing challenges

The growth in the formulation of drugs suitable for delivery by subcutaneous (Sub-C) injection...

admin-element

Articles Regulatory

August 25, 2023

A risk based approach to sterile filtration

Drug quality cannot be assured only by finished-product testing. Process validation is required to...

admin-element

Articles BioPharma Downstream Upstream

May 9, 2019

Single-Use for Downstream Chromatography: Benefit or Hindrance?

Biopharmaceutical manufacturers have embraced the use of single-use technology upstream, but are...

admin-element

Articles BioPharma Downstream Regulatory Upstream

November 19, 2015

Selecting the Right Viral Clearance Technology

The introduction of adventitious viral agents is a recognized, inherent risk of biologic drug...

admin-element